Proteostasis Therapeutics Inc (PTI)

[TommyBoyTrader9460]

$pti...would love to see a $1 pop and run here...

[Inoviorulez]

Hopefully that increase in volume for PTI continues.

[ClayTrader]

* * $PTI Video Chart 11-06-19 * *

Link to Video - click here to watch the technical chart video

[TommyBoyTrader9460]

$pti...huge buying volume pouring in now...

[Inoviorulez]

Good news, looks like enrollment is now complete for doublet and Triplet for PTI's studies. Data now expected Q4 2019.

[Inoviorulez]

It's possible, we have to see how presentations tomorrow go for PTI.

[steph1971]

seems like the turn around could be coming?

[BuyFordNow]

Morning,Clemdane,thanks for the comeback, Let's see for today, The ask 10,Bid now 5, That's 100% on a contract .,let's move it on up, Luck

[Clemdane]

No news! But looking back over it, PTI still has 5 analysts with "Buy ratings" with an average price target of $8.75! Recently Piper Jaffray said they think PTI will recover. So I'm clinging to that.

[BuyFordNow]

Greetings,Anybody got any news here today ???

[Full Contact Yoga]

Nice steady last couple of days.

[TJG]

PTI Low Outstanding share count, just over 51,000,000 company news will have this moving upwards shortly.

[TJG]

Latest headlines... EU grants Orphan Drug status for PTI CF drug(s)

http://ir.proteostasis.com/news-releases/news-release-details/proteostasis-therapeutics-receives-orphan-drug-designation-eu

[TJG]

New investors need to check out their web site...this company is ahead of the competition when it comes to working with Cystic Fibrosis patients.

http://www.proteostasis.com/

[TJG]

Getting ready for a major break out... $10 year end price target

https://new.nasdaq.com/market-activity/stocks/pti

[ClayTrader]

* * $PTI Video Chart 06-07-2019 * *

Link to Video - click here to watch the technical chart video

[Full Contact Yoga]

Seems to always be a premarket bounce followed by drops. Yesterday through today no different.

[ClayTrader]

* * $PTI Video Chart 06-04-2019 * *

Link to Video - click here to watch the technical chart video

[GEEZ]

Short squeeze is on

[NotTheFace1337]

Looking good today

[Golden Cross]

Bounced nice here today...

[ClayTrader]

* * $PTI Video Chart 03-26-2019 * *

Link to Video - click here to watch the technical chart video

[GEEZ]

Shorts still in control here

[Longer Than Most]

$PTI gap fill

[Golden Cross]

Looking for a rebound here...

[aristotelisonassis]

$1.38 (+5,34%) in AH trading is not bad for beginning.

[ClayTrader]

* * $PTI Video Chart 03-25-2019 * *

Link to Video - click here to watch the technical chart video

[GEEZ]

There won t be no runner here...only 3 mms here

[GEEZ]

Good call on thehold..bouncing of 52 week low.. was all small trades bringing it down

[GEEZ]

Willi bone do your dd it was a phase one ..llol

[aristotelisonassis]

i think we have an after hour runner ladies and gents. Hold on to your pants.

[aristotelisonassis]

holding overnight.

[aristotelisonassis]

Strong buy here. Very cheap. Could bounce hard the next days. Totally oversold. Shorts will cover soon.

[aristotelisonassis]

totally oversold. Long here.

[willlbone]

Phase 2 Fail.

[WBillCody]

Anything under $5 is money ??

[ClayTrader]

* * $PTI Video Chart 02-11-2019 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $PTI Video Chart 12-17-18 * *

Link to Video - click here to watch the technical chart video

[ALERTS100%to10000%GAIN]

PTI~~HUGE NEWS~~~Proteostasis Therapeutics Announces Global License Agreement with Genentech
7:00 am ET December 17, 2018 (PR Newswire) Print
Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced a worldwide, exclusive license agreement with Genentech, a member of the Roche Group, for rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network. The agreement does not include cystic fibrosis transmembrane conductance regulator (CFTR) modulators and is unrelated to PTI's investigational medicines or other ongoing research programs in cystic fibrosis.
The proteostasis network consists of more than 1,000 proteins organized into pathways that can be regulated or targeted by drugs. Genetic mutations, environmental factors, and aging can cause the proteome to become imbalanced, which can lead to a decrease in protein quality control leading to a wide range of diseases including cancer.
Under the terms of the agreement, in exchange for rights to these small molecule modulators, Proteostasis is eligible to receive upfront and milestone payments of over $100 million. In addition, Proteostasis is eligible to receive tiered royalties on sales of medicines resulting from the license agreement. Genentech is responsible for all further research and development expenses related to the program. Full financial terms, the therapeutic target and disease areas of focus are not disclosed.
"We are thrilled to enter into this agreement with Genentech, an industry leader with a proven record of success in small molecule research and development," said Meenu Chhabra, President and CEO of Proteostasis Therapeutics. "PTI's platform revolves around the modulation of protein homeostasis pathways within the cell, either restoring its normal state or enhancing its capacity to control or delay the progression of disease. We look forward to working with Genentech to leverage discoveries from this platform to potentially address unmet medical needs."
About Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis and other diseases caused by dysfunctional protein processing. Headquartered in Boston, MA, the Proteostasis Therapeutics team focuses on identifying therapies that restore protein function. For more information, visit www.proteostasis.com.
Safe Harbor
To the extent that statements in this release are not historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "aim," "may," "will," "expect," "anticipate," "estimate," "intend," and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Examples of forward-looking statements made in this release include, without limitation, statements regarding expected receipt of the upfront payment, future milestone-based payments and royalties which may be paid by Genentech to Proteostasis Therapeutics, and the potential for the platform or target to yield treatments addressing unmet medical need. Forward-looking statements made in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we, therefore cannot assure you that our plans, intentions, or expectations for our technology will be attained or achieved. Such risks and uncertainties include, without limitation, the possibility that Proteostasis Therapeutics may not realize the potential benefits of this licensing arrangement, and those set forth in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 and our other SEC filings. We assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
https://c212.net/c/img/favicon.png?sn=NE03381&sd=2018-12-17
View original content:www.prnewswire.com/news-releases/proteostasis-therapeutics-announces-global-license-agreement-with-genentech-300766088.html

[stocktrademan]

PTI buy 4.81

bull flag
filled in or touched the gap up and now resuming uptrend
double bottom (or some would consider it an inverted head and shoulders bottom)
symmetry (from traders using support and resistance trendlines)
recent news catalyst
SCTR chart rating bullish above its 50 midpoint



http://www.proteostasis.com/

recent gap up due to positive clinical trial results for Cystic Fibrosis therapies

Proteostasis Therapeutics Announces Positive Preliminary Results from Proprietary Doublet in Cystic Fibrosis Patients
http://ir.proteostasis.com/news-releases/news-release-details/proteostasis-therapeutics-announces-positive-preliminary-results
























normal chart




log chart

[simmons420]

Nice long and strong

[Clemdane]

I know! I'm amazed that this board isn't more active. Guess this one is still a "sleeper." I'm already up 24% in a matter of days.

[Inoviorulez]

ended up going slightly over with 11 million shares but good price 6.75 so not that bad. I'm happy I think it will head higher once dilution is over. That means it won't start move up prob till next week.

[Sy-ATDS]

MMs in a desperate attempt to keep it below 8:)))

[Sy-ATDS]

Seems really undervalued given multi billion players in this domain.

[Sy-ATDS]

Not a huge public offering! Good.

[Inoviorulez]

https://seekingalpha.com/article/4213207-proteostasis-therapeutics-surges-cystic-fibrosis-data-can-run-continue

[Sy-ATDS]

Big question is, will Positive triplet results expected anytime this quarter would see another 400% day?hmmm!

[Sy-ATDS]

Profit taking seems to have ended now; good base to move up even without news IMO.

[TheMarketWizard]

Well now it fell below $9. Financial report, balance sheet, revenue, earnings overall..... def not going to invest in that. Shorting it down to $3.